Upgrade for Complete Access See Plans and Pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Dow
McKesson
Harvard Business School
Baxter
Merck

Last Updated: December 7, 2021

DrugPatentWatch Database Preview

Litigation Details for ELI LILLY AND COMPANY v. PERRIGO COMPANY (S.D. Ind. 2013)


Email this page to a colleague

« Back to Dashboard

ELI LILLY AND COMPANY v. PERRIGO COMPANY (S.D. Ind. 2013)

Docket ⤷  Try it Free Date Filed 2013-05-24
Court District Court, S.D. Indiana Date Terminated 2016-09-22
Cause 35:145 Patent Infringement Assigned To Sarah Evans Barker
Jury Demand None Referred To Denise K Larue
Parties ELI LILLY AND COMPANY; PERRIGO ISRAEL PHARMACEUTICALS LTD.
Patents 6,299,900; 6,319,913; 6,503,894; 6,818,226; 6,923,983; 8,071,075; 8,419,307; 8,435,944; 8,807,861; 8,993,520
Attorneys Danielle A. Duszczyszyn; Jennifer M. Vein
Firms Mattingly Burke Cohen & Biederman LLP; SCHUCKIT & ASSOCIATES - Zionsville
Link to Docket External link to docket
Small Molecule Drugs cited in ELI LILLY AND COMPANY v. PERRIGO COMPANY
The small molecule drugs covered by the patents cited in this case are ⤷  Try it Free , ⤷  Try it Free , ⤷  Try it Free , and ⤷  Try it Free .

Details for ELI LILLY AND COMPANY v. PERRIGO COMPANY (S.D. Ind. 2013)

Date Filed Document No. Description Snippet Link To Document
2013-05-24 1 Exhibit C - Patent US 8,177,449 B2 Exhibit A - Patent US 8,435,944 B2, # 2 Exhibit B - Patent US 8,419,307 B2, # 3 Exhibit C - Patent US 8,177,449… 22 September 2016 1:13-cv-00851 830 Patent None District Court, S.D. Indiana External link to document
2015-04-29 124 Complaint for Patent Infringement), # 2 Exhibit A (U.S Patent No. 6,299,900), # 3 Exhibit B (U.S. Patent No. 6,818,226…U.S. Patent No. 6,923,983), # 5 Exhibit D (U.S. Patent No. 8,071,075), # 6 Exhibit E (U.S. Patent No. …U.S. Patent No. 8,435,944), # 8 Exhibit G (U.S. Patent No. 8,177,449), # 9 Exhibit H (U.S. Patent No. …. 8,807,861), # 10 Exhibit I (U.S. Patent No. 8,993,520), # 11 Text of Proposed Order)(Masurovsky, Laura… 22 September 2016 1:13-cv-00851 830 Patent None District Court, S.D. Indiana External link to document
2015-04-30 128 (U.S Patent No. 6,299,900), # 2 Exhibit B (U.S. Patent No. 6,818,226), # 3 Exhibit C (U.S. Patent No. …U.S. Patent No. 8,071,075), # 5 Exhibit E (U.S. Patent No. 8,419,307), # 6 Exhibit F (U.S. Patent No. …U.S. Patent No. 8,177,449), # 8 Exhibit H (U.S. Patent No. 8,807,861), # 9 Exhibit I (U.S. Patent No. … 22 September 2016 1:13-cv-00851 830 Patent None District Court, S.D. Indiana External link to document
2015-05-21 134 .S. Patent No. 8,435,944, # 2 Exhibit . B - U.S. Patent No. 8,419,307, # 3 Exhibit C - U.S. Patent No.…8,177,449, # 4 Exhibit D - U.S. Patent No. 8,807,861, # 5 Exhibit E - U.S. Patent No. 8,993,520)(Zweig, Sally… 22 September 2016 1:13-cv-00851 830 Patent None District Court, S.D. Indiana External link to document
2015-09-03 163 Proposed Letter Request with Ex. A - U.S. Patent No. 8,071,075 B2 and Ex. B - Protective Order)(Clark, … 22 September 2016 1:13-cv-00851 830 Patent None District Court, S.D. Indiana External link to document
2015-09-03 164 # 2 Exhibit 1 to Hoang Declaration U.S. Patent No. 8,071,075 B2, # 3 Exhibit 2 to Hoang Declaration Acruxs… 22 September 2016 1:13-cv-00851 830 Patent None District Court, S.D. Indiana External link to document
2016-01-05 219 STIPULATION as to U.S. Paten Nos. 8,177,449 and 8,419,307, filed by Consol Defendant ACTAVIS LABORATORIES… 22 September 2016 1:13-cv-00851 830 Patent None District Court, S.D. Indiana External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Moodys
Harvard Business School
Colorcon
McKinsey
Merck
AstraZeneca

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.